Melanomas are derived from the neural crest and therefore have low endogenous EGFR expression, which explains the stunning intrinsic difference in drug sensitivity of two cancer types that are driven by the same mutation (Prahallad et al. 2012). The gene discussed is EGFR; the disease is cancer.